Anti-ANKRD30A Antibody

A polyclonal reagent from Antibodies.com targets ANKRD30A, the protein also known as NY-BR-1, a breast-tissue differentiation marker that has been investigated as a candidate antigen in breast cancer research and tumor immunology. The antibody is raised in rabbit, supplied as an unconjugated antiserum in a 100 µL volume, and is validated for western blot, immunohistochemistry, and ELISA workflows against human samples. Investigators studying mammary epithelial differentiation or screening panels of breast carcinoma specimens for differential diagnosis will find the host species, isotype profile, and lack of conjugation allow flexible pairing with secondary detection reagents of their choice. Storage at -20 °C in small aliquots helps preserve activity across multiple freeze-thaw cycles, and the polyclonal nature of the reagent supports broad recognition of epitopes across the target for research use only applications.